Linked Life Data

19663611

Source:http://linkedlifedata.com/resource/pubmed/id/19663611

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13
pubmed:dateCreated
2009-8-11
pubmed:abstractText
Iloprost, as a stable analog of endogenous prostacyclin, has far-reaching pharmacological effects. For several years already it has been used successfully in its intravenous and inhalative forms for treating patients with pulmonary hypertension (PH). Since the development of efficient nebulizers that guarantee a constant output of the effective agent, inhalative iloprost has become an important alternative in the drug treatment of PH. Inhalative iloprost is an effective and safe partner for other classes of substances in combination therapy, which is becoming ever more frequently necessary. In addition, it is also used in the acute testing of pulmonary vasoreactivity and in intensive care therapy of manifest right heart failure.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1744-7666
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2195-207
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Inhalative iloprost - pharmacology and clinical application.
pubmed:affiliation
Ernst-Moritz-Arndt University Greifswald, Friedrich-Loeffler-Strasse 23a, D-17475 Greifswald, Germany.
pubmed:publicationType
Journal Article